HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Avon Readies Anew Offering For Ultimate Anti-Aging Defense

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Avon is expanding its Anew anti-aging franchise with AnewUltimate Skin Transforming Cream and extensions to its Retroactive line

You may also be interested in...



Avon Beyond Color Foundation, Luminosity Ultra Headline Q1 Launches

Avon is unleashing a full product pipeline next year starting in the first quarter with the launches of Beyond Color Perfecting Foundation and Anew Luminosity Ultra, as well as the relaunch of AnewSolutions, according to CEO Andrea Jung

Avon Beyond Color Foundation, Luminosity Ultra Headline Q1 Launches

Avon is unleashing a full product pipeline next year starting in the first quarter with the launches of Beyond Color Perfecting Foundation and Anew Luminosity Ultra, as well as the relaunch of AnewSolutions, according to CEO Andrea Jung

Avon Fall TV, Print Ad Campaign Aims For Ultimate Impression

Avon is launching a TV ad campaign Sept. 23 to promote the fall launch of Anew Ultimate Skin Transforming Cream, the company said

Table

View full table

Related Content

HBW Insight
HBW Insight
HBW Insight
Tags:
Latest Headlines

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

See All
UsernamePublicRestriction

Register

RS010288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By